| Old Articles: <Older 8841-8850 Newer> |
|---|
 |
Chemistry World
May 21, 2014
Phillip Broadwith |
Novartis enhances its focus with eyecare deal Swiss pharma major Novartis is continuing its quest to excel in a few specialist fields by licensing rights to US firm Ophthotech's lead candidate, Fovista, for wet age-related macular degeneration.   |
Chemistry World
May 21, 2014
Phillip Broadwith |
Abbott to buy Chile's CFR for $3bn The move will bolster Abbott's position in the rapidly growing markets of Latin America. |
Information Today
May 20, 2014 |
EBSCO Adds Medical Ebook Collections EBSCO Information Services rolled out three new Medical Featured Collections on its EBSCO eBooks and Audiobooks platform that libraries can purchase individually or as a collection. |
Chemistry World
May 19, 2014
Phillip Broadwith |
AstraZeneca refuses Pfizer's 'final' offer The US giant has described this proposal, valuing AZ at 70 billion pounds, as 'final' and says it 'cannot be increased'. |
Chemistry World
May 15, 2014
Phillip Broadwith |
Lilly protests $450m Brazilian fine The Brazilian subsidiary of pharma major Eli Lilly has been ordered to pay a $450 million fine by a local court. |
Chemistry World
May 14, 2014
Andy Extance |
Pfizer presses hard for AstraZeneca deal US pharma giant Pfizer is battling a backlash of suspicion and hostility across the world over its attempts to acquire its UK-headquartered rival AstraZeneca. |
Chemistry World
May 14, 2014
Phillip Broadwith |
Chinese police hand GSK bribery case to prosecutors The Chinese state news agency Xinhua has released details of the police investigation, claiming that 46 suspects are involved including Mark Reilly, former manager of GSK China. |
Chemistry World
May 9, 2014
Andy Extance |
Bayer wins race to buy Merck & Co consumer care Germany's Bayer has won a bidding contest for US giant Merck & Co's consumer care business unit, seemingly thanks to a heart drug collaboration sweetener. |
Chemistry World
May 7, 2014
Phillip Broadwith |
Insider trading allegations stall Sun -- Ranbaxy deal The merger deal that would create India's largest pharmaceutical company has been stalled by accusations of insider trading of shares in the lead-up to the takeover announcement. |
Chemistry World
May 7, 2014
Phillip Broadwith |
UK regulator warning over online herbal remedies The UK's Medicines and Healthcare products Regulatory Agency has found that several herbal medicines available over the internet are contaminated with prescription-only drugs or toxic heavy metals. |
| <Older 8841-8850 Newer> Return to current articles. |
